how long does nausea last after first dose of semaglutide Timeline: When It Start? What to do if a

Study Snapshot Design: Randomized, double-blind, placebo-controlled trial Duration: 26 weeks Population: Treatment-seeking adults with AUD + obesity Completers: 88 participants Intervention: Once-weekly semaglutide + behavioral therapy Funding: Novo Nordisk Foundation Key Findings (Simplified) Heavy drinking days significantly reduced ~41% reduction with semaglutide vs ~26% placebo Treatment effect difference: ~13.7% improvement vs placebo Absolute reduction: ~12 fewer heavy drinking days/month (vs ~8 days in placebo) Alcohol-Related Outcomes Total alcohol intake Frequency of binge/heavy drinking episodes Alcohol craving (supported by prior trials) Biomarker-confirmed reductions in alcohol exposure Metabolic & Somatic Benefits Significant weight loss Improved blood pressure & cardiometabolic profile Reinforces dual benefit: metabolic + behavioral modulation Mechanistic Insight (Emerging) GLP-1 receptor agonists may: Modulate reward pathways Reduce dopamine-driven craving signals Decrease cue-induced alcohol seeking behavior Important Limitations Small sample size (n=88 completers) Conducted in motivated, treatment-seeking population Combined with cognitive behavioral therapy (not drug-only effect) No long-term post-treatment follow-up Why This Matters AUD remains under-treated globally Current pharmacotherapies have limited uptake & modest efficacy Semaglutide introduces a novel, biologically plausible pathway Potential shift toward metabo-psychiatric therapeutics Clinical Takeaway This is not just a weight-loss drug anymore It may represent a new frontier in addiction medicine But: Larger, real-world trials are essential before routine clinical adoption

The peptide promotes angiogenesis, the formation of new blood vessels that deliver nutrients and oxygen to injured tissues

We have collaborated with more than 50 brands and cosmetic companies, such as Watsons, Walmart, and Beijing TongRenTang, and have obtained certifications including GMPC, ISO22716, and SGS

These include glutamine, glycine and cysteine